For: | Giri S, Anirvan P, Angadi S, Singh A, Lavekar A. Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease. World J Gastrointest Pathophysiol 2024; 15(1): 91100 [PMID: 38682026 DOI: 10.4291/wjgp.v15.i1.91100] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v15/i1/91100.htm |
Number | Citing Articles |
1 |
Mohamed El-Kassas, Heba A. Othman, Mohamed Elbadry, Khalid Alswat, Yusuf Yilmaz. Risk Stratification of Patients with Metabolic Dysfunction-associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2025; 15(1): 102415 doi: 10.1016/j.jceh.2024.102415
|
2 |
Fan Zhang, Longgen Liu, Wenjian Li. Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01081-0
|